Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 909 out of 157,372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 44,422 | 37,314 |
| Total Cites | 1,585 | 1,948 |
| H-index | 15 | 17 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 14 | 17 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 91 | 111 |
| Number of Single+First+Last Authored Papers | 128 | 128 |
| Total Cites to Single+First+Last Authored Papers | 225 | 267 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 1,207 | 1,418 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.37 |
| Self-Citation Percentage |
18.63%
|
|
Niemeyer, Charlotte M.
Albert Ludwigs Universität Freiburg, Medizinische Fakultät,
Germany
2023 Rank: 32,710
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 754 out of 147,556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32,710 | 31,641 |
| Total Cites | 1,313 | 1,521 |
| H-index | 17 | 18 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 30 | 30 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 109 | 121 |
| Number of Single+First+Last Authored Papers | 128 | 128 |
| Total Cites to Single+First+Last Authored Papers | 245 | 275 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 989 | 1,109 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.37 |
| Self-Citation Percentage |
13.68%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 823 out of 138,599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 30,486 | 27,081 |
| Total Cites | 1,273 | 1,555 |
| H-index | 17 | 19 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 28 | 32 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 117 | 142 |
| Number of Single+First+Last Authored Papers | 127 | 127 |
| Total Cites to Single+First+Last Authored Papers | 275 | 324 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 932 | 1,063 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.46 |
| Self-Citation Percentage |
18.14%
|
|
Niemeyer, Charlotte M.
Albert Ludwigs Universität Freiburg, Medizinische Fakultät,
Germany
2021 Rank: 39,105
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 938 out of 127,911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 39,105 | 36,157 |
| Total Cites | 1,722 | 2,002 |
| H-index | 18 | 20 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 30 | 33 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 152 | 165 |
| Number of Single+First+Last Authored Papers | 125 | 125 |
| Total Cites to Single+First+Last Authored Papers | 377 | 412 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,252 | 1,418 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.41 |
| Self-Citation Percentage |
13.99%
|
|
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.